drugset / Trial / NCT00607802

Donor White Blood Cell Infusion in Treating Patients With Metastatic or Unresectable Cancer

NCT00607802 ↗

Treatment

Summary

RATIONALE: White blood cells from donors may be able to kill cancer cells in patients with cancer. PURPOSE: This clinical trial is studying the side effects of donor white blood cell infusion in treating patients with metastatic or unresectable cancer.

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject leukocyte therapy Cell therapy — —